Newsroom | 37250 results

SAN DIEGO--(BUSINESS WIRE)--Fans who donate to support cancer research at Fandiem through April 30 earn a chance to win a trip to San Diego, score VIP table seats and meet P!NK....

ORLANDO--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, will bring together breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the Central Florida MORE THAN PINK Walk on Saturday, May 9, 2026. The Orlando community will come together to make sure no one faces breast cancer alone and help advance Komen’s mission to save lives through research, public policy, education and care. This year, Komen aims to raise $210,000 at...

LAS VEGAS--(BUSINESS WIRE)--Molina Healthcare of Nevada invests over $400,000 in support of enhanced behavioral health services and access to care across the state....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuVia Inc., a biotechnology company developing first-in-class therapies for solid tumors, today announced that it has selected Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, as a strategic technology partner. ImmuVia will deploy Quantori’s Q-Scientist platform to streamline computational workflows across its preclinical programs, with the goal of compressing development timeline...

ROCKVILLE, Md.--(BUSINESS WIRE)--Linden Lake Labs (“L3”), an early-stage life sciences platform committed to advancing innovative therapies, today announced that its portfolio company, CrossBridge Bio, has entered into a definitive agreement to be acquired by Eli Lilly and Company. Linden Lake Labs participated in CrossBridge Bio’s seed financing round in November 2024, supporting the early development of its differentiated dual-payload antibody-drug conjugate (ADC) platform. “This milestone re...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Antiva reports Phase 1b/2 data showing ABI-2280 clears high-risk HPV with strong efficacy, durability, and safety vs placebo....

CORVALLIS, Ore. & MEDFORD, Mass.--(BUSINESS WIRE)--BioTesserae Inc. (BTC), a biotechnology company focused on innovative veterinary therapeutics, in collaboration with Sunflower Therapeutics PBC, a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, today announced that BTC-001 was well tolerated in healthy dogs following a single ascending dose study. BTC-001 is a single domain antibody (SdA) that recognizes the immune checkpoint in...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (Nasdaq: LTRN) (“Lantern” or the “Company”), an AI-driven clinical-stage precision oncology company, today announced that withZeta.ai — the world’s first and most comprehensive multi-agentic AI co-scientist for rare cancer drug discovery, development, biomedical research, molecular design and clinical trial development — is now commercially live and actively onboarding subscribers. Subscriptions are available immediately at withzeta.ai, spanning intr...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces New Manuscript Demonstrating Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies...

Lausanne, Suisse--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), société biopharmaceutique indépendante basée en Suisse dont la vocation est de mettre au point les traitements de référence de demain afin de guérir le cancer et les maladies infectieuses, présentera de nouvelles données révolutionnaires lors du congrès annuel 2026 de l’American Association for Cancer Research (AACR) à San Diego, en Californie. L’un des temps forts de la participation au congrès de cette année sera la première...